Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Prostate. 2011 Nov 29;72(10):1140–1149. doi: 10.1002/pros.22463

Fig. 1. Determination of plasma sPLA2-IIa in prostate cancer patients.

Fig. 1

Plasma samples from prostate cancer patients were diluted ten times and then subjected to ELISA analysis in duplicate for each sample. The average was calculated as pg/ml based on the standard curve of each experiment. Two samples from stage T3 prostate cancer are above the scale. The dotted line indicates 2.0 ng/ml cutoff value.